Dr. Mirmirani examines the current treatment landscape for extensive and severe alopecia areata, focusing on longstanding unmet needs and how recent FDA-approved therapies are beginning to close critical treatment gaps. Her discussion emphasizes practical considerations for managing complex cases and improving long-term patient outcomes.
Topics Covered
- Challenges in treating extensive and severe alopecia areata
- Limitations of traditional therapeutic approaches
- Overview of recently FDA-approved treatment options
- What new approvals mean for patient access and care strategies
Explore Related Resources:
Use-of JAK Inhibitors for Patients with Alopecia Areata
Assessing the Safety and Efficacy of Deuruxolitinib in Patients with Alopecia Areata
